Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma-Reference-Cited by-同舟云学术

Epigenetic modulation enhances immunotherapy for pancreatic ductal adenocarcinoma

Published:2022-01 Issue:12 Volume:11 Page:
ISSN:2050-0068
Container-title:Clinical & Translational Immunology
language:en
Short-container-title:Clin & Trans Imm

Author:

Li Yan¹²,Hong Young K¹³,Wang Xingtong¹⁴,Pandit Harshul¹²,Zheng Qianqian¹⁵^ORCID,Yu Youxi¹⁴,Shi Xiaoju¹⁴,Chen Yujia¹⁴,Tan Min¹,Pulliam Zachary¹,Bhutiani Neal¹,Lin Andrew³,Badach Jeremy³,Zhang Ping³,Martin Robert CG¹²^ORCID

Affiliation:

1. Division of Surgical Oncology, Hiram C. Polk Jr., M.D. Department of Surgery School of Medicine, University of Louisville Louisville KY USA

2. Department of Pharmacology & Toxicology University of Louisville School of Medicine Louisville KY USA

3. Division of Surgical Oncology, Department of Surgery Cooper University Hospital Camden NJ USA

4. The First Hospital of Jilin University, Jilin University Changchun China

5. Basic Medicine College, China Medical University Shenyang China

Publisher

Wiley

Subject

General Nursing,Immunology,Immunology and Allergy

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cti2.1430

Reference50 articles.

1. Cancer statistics for the year 2020: An overview

2. Pancreatic Ductal Adenocarcinoma: Relating Biomechanics and Prognosis

3. Trends in the utilization of neoadjuvant therapy for pancreatic ductal adenocarcinoma

4. Perioperative and survival outcomes following neoadjuvant FOLFIRINOX versus gemcitabine Abraxane in patients with pancreatic adenocarcinoma;Chapman BC;JOP,2018

5. Reducing lung cancer progression with immunotherapy;Voelker R;JAMA,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Novel insights into TCR-T cell therapy in solid neoplasms: optimizing adoptive immunotherapy;Experimental Hematology & Oncology;2024-04-03

2. Clinical characteristics and novel strategies of immune checkpoint inhibitor rechallenge therapy for non-small cell lung cancer: a comprehensive review;Frontiers in Immunology;2024-01-12

3. Epigenetic therapeutic strategies in pancreatic cancer;International Review of Cell and Molecular Biology;2024

4. Targeting one‐carbon metabolism for cancer immunotherapy;Clinical and Translational Medicine;2024-01

5. PD-L1 Downregulation and DNA Methylation Inhibition for Molecular Therapy against Cancer Stem Cells in Hepatocellular Carcinoma;International Journal of Molecular Sciences;2023-08-29